SOX17 and neoplasm: For example, in cells and animal models, SOX17 poorly expresses in ESCC cells and tumor tissues; at the same time, overexpression of SOX17 could sensitize ESCC irradiation-resistant cells to irradiation, cisplatin and concurrent chemoradiation therapy treatment [9].